Millennium Pharmaceuticals

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.11, 2004-11, pp. : 1605-1608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Millennium Pharmaceuticals has stopped further accrual into its phase II clinical trial investigating the efficacy of bortezomib

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pharmaceuticals and Doping

By Scheiff Anja

PHARMAKON, Vol. 4, Iss. 1, 2016-01 ,pp. : 22-29

Govi-Verlag

Access to resources Recommend Favorite

Market Exclusivity Strategies for Pharmaceuticals

By Luchetti Cynthia

Pharmaceutical Medicine, Vol. 23, Iss. 2, 2009-04 ,pp. : 77-84

Adis International

Access to resources Recommend Favorite

Quality Control in the Regulation of Pharmaceuticals

By Adis International Limited

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 421-422

Adis International

Access to resources Recommend Favorite

Ovation Pharmaceuticals, Inc.

By Deutsch Barry

Pharmacogenomics, Vol. 3, Iss. 6, 2002-11 ,pp. : 839-841

Future Medicine

Access to resources Recommend Favorite